Published in Law and Health Weekly, December 9th, 2006
Nilamadhab Mishra, MD, and colleagues reported at the American College of Rheumatology meeting in Washington that the two drugs - TSA (trichostatin A) and SAHA (suberoylanilide hydroxamic acid ) - decreased cholesterol deposits in the walls of arteries.
The two drugs are part of a class of drugs called histone deacetylase inhibitors, or HDIs, which work by multiple mechanisms, one of which is anti-inflammatory: they decreased...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.